Background: Open surgical release of the A1 pulley is the definitive treatment for the common hand condition of trigger finger, or inflammatory stenosing tenosynovitis. Anecdotal evidence among hand surgeons has questioned whether or not recent steroid injection may be related to complications following open trigger finger release, particularly wound infection, but no studies have primarily studied this connection to date. We aimed to determine whether recent steroid injection was associated with postoperative surgical infections. Methods: We performed a retrospective chart review of 780 adult patients who had undergone open trigger finger release of 999 digits by 6 fellowship-trained hand surgeons at three affiliated hospital settings from January 1, 2014, to January 1, 2016. Data on timing of steroid injections relative to surgery, number of steroid injections, concomitant conditions, use of antibiotics, and postoperative complications including infections were gathered. Results: Steroid injection timing relative to subsequent operative intervention correlated with postoperative surgical site infection in trigger finger release. Older age and decreasing days between steroid injection and surgery correlated with infection rates. Other factors found to be associated with infection rates included smoking, use of preoperative antibiotics, and use of lidocaine with epinephrine. The other factors examined did not correlate with infection rates. Conclusions: Steroid injection, smoking, increasing age, lesser number of days between steroid injection and surgery, and use of lidocaine with epinephrine are risk factors for postoperative trigger surgical infections. We recommend careful preoperative counseling regarding higher wound healing risks for smokers, avoidance of steroid injections immediately prior to an operative date, and scheduling operative dates that tend to be greater than 80 days from the date of last steroid injection. We also recommend avoidance of epinephrine in the local anesthetic solution, as this may minimize surgical site infection risks.

Background Percutaneous needle biopsy has been found to be a safe and accurate method for the initial investigation of soft tissue masses. The notion exists that needle biopsies should be performed in specialized sarcoma centers, which can place a financial burden on patients without a sarcoma center near their place of residence. There is no consensus in the current literature regarding the diagnostic accuracy and clinical utility of clinic-based percutaneous core needle biopsy performed by community orthopedic surgeons with fellowship training in musculoskeletal oncology. Questions/Purposes Our primary goal was to determine if office-based core needle biopsy of soft tissue masses could safely yield accurate diagnoses when performed by a community orthopedic surgeon with fellowship training in musculoskeletal oncology. Patients and Methods We retrospectively reviewed the charts of 105 patients who underwent percutaneous core needle biopsy of soft tissue masses in a community clinic. All procedures were performed by one fellowship-trained musculoskeletal oncologist. Accuracy of the initial clinic-based needle biopsy was determined through comparison to the results of pathological analysis of the surgically excised masses. Final data analysis included 69 patients who underwent both clinic-based biopsy and subsequent surgical excision of their masses. Results We found clinic-based biopsies to be 87.0% accurate for exact diagnosis and 94.2% accurate in determining whether the mass was benign or malignant (p < 0.0001). Minor complications related to the clinic-based biopsy occurred in 5.80% of cases, with no documentation of major complications. Conclusions Our results provide evidence that office-based percutaneous biopsy can be administered safely and yield accurate, clinically useful results when performed by a fellowship-trained musculoskeletal oncologist.

No abstract

Objective: There are limited biomechanical data supporting the use of anterior or superior-lateral precontoured clavicle plates for the treatment of displaced Neer type II-A clavicle fractures. The objectives of this study were as follows: (a) compare noncontoured versus precontoured superior plating; (b) compare use of locking versus nonlocking screws in the lateral fragment for superior precontoured plates; and (c) compare superior versus anterior precontoured plates with locking lateral fragment screws. Methods: The following constructs were tested on a synthetic clavicle model simulating a Neer type II-A fracture: (a) superior precontoured plate with locking (SUP-L, n = 6); (b) superior precontoured plate with nonlocking (SUP-NL, n = 8); (c) anterior precontoured plate with locking (ANT-L, n = 7); and (d) superior noncontoured locking compression plate (SUP-LCP, n = 6). Constructs were subjected to cyclical cantilever loads. Construct stiffness and survival (cycles to failure) were documented. Mann–Whitney U tests were performed for group-wise statistical comparison (α = 0.05) of data. Results: The SUP-L construct was significantly stiffer than both SUP-LCP and ANT-L constructs (P < 0.02). The SUP-NL construct was stiffer than the SUP-L (P = 0.03) construct. Both SUP-L and ANT-L precontoured constructs survived longer than the noncontoured SUP-LCP construct (P < 0.022). The SUP-L construct survived longer than the SUP-NL (P = 0.013) and the ANT-L (P = 0.008) constructs. Conclusions: Superior precontoured plates yielded biomechanically superior constructs compared with anterior precontoured and superior noncontoured plates. Using locking screws in the lateral fragment over nonlocking screws may improve overall superior precontoured plate construct survivability. However, our results were limited to a synthetic biomechanical model and require further investigation to establish a clinical correlation.

Obesity is associated with increased surgical complications that may lead to suboptimal total knee arthroplasty (TKA) outcomes. Additionally, females exhibit increased rates of severe, clinical osteoarthritis OA, along with increased ligamentous laxity. Therefore, obese females present a particularly challenging case for TKA with increased joint loads coupled with a propensity for instability. This study retrospectively analyzed knee range of motion and stability of one TKA designs with two different degrees of polyethylene conformity in the obese female population. The implants (Stryker Triathlon total stabilizing [TS] and Stryker Triathlon posterior stabilizing [PS]) differ in their level of constraint, with the TS being more constrained. We hypothesized that the TS implants would be associated with improved functional outcomes in the obese female population, secondary to increased coronal stability to offset the ligamentous laxity. Of 482 knees reviewed, 173 met the inclusion criteria of: female, body mass index (BMI) ≥ 25, receiving TS ( = 93), or PS ( = 8). Primary knee outcome measures were: active flexion, passive flexion, active extension, passive extension, and stability at 0° and 30° flexion. These factors were statistically analyzed at preop, 2-week, 6-week, 3-month, and 1-year time points. Preoperatively, the TS cohort was significantly higher in BMI and knee laxity, potentially starting this cohort at a functional disadvantage. Postoperatively, the TS implant was associated with a statistically significant early improvement in active and passive knee extension. There was no longer any significant difference in knee laxity postop. Our data support the hypothesis that obese females may benefit from the increased stability afforded by the TS design.